PainReform Shares Gain 11%

Shares of PainReform Ltd. (PRFX) are gaining over 11% on Wednesday morning despite no stock-related news to drive the shares. The U.S. stocks opened higher on Wednesday.

PRFX is currently trading at $3.52, up $0.37 or 11.746%, on the Nasdaq, on a volume of 5.1 million shares, up from average volume of 263 thousand. The stock has traded between $2.18 and $7.85 in the 52 week period.

PainReform, a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Follow RTT